Safety and efficacy analysis of PD-1 inhibitors in combination with chemotherapy for advanced pancreatic cancer

被引：3

作者：

Song, Dong ^{[1
,2
]}

Yang, Xuejing ^{[1
,2
]}

Guo, Xin ^{[1
,2
]}

Sun, Hu ^{[1
,2
]}

机构：

[1] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan 030032, Peoples R China

[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China

来源：

IMMUNOTHERAPY | 2022年 / 14卷 / 16期

关键词：

advanced pancreatic cancer; adverse effects; immunotherapy; PD-1; inhibitors; TUMOR MICROENVIRONMENT;

D O I：

10.2217/imt-2022-0196

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Plain language summary In recent years, encouraging results have been achieved with a new treatment for advanced cancer, immunotherapy. Immune checkpoint inhibitors are now being used as a more established form of immunotherapy. During immunotherapy, immune checkpoint inhibitors effectively dismantle the 'camouflage' of tumor cells, allowing immune cells to regain the ability to recognize and remember them, allowing the body's immune cells or drugs to kill tumor cells with precision. This study analyzed 18 patients with advanced pancreatic cancer, in whom immunotherapy in combination with chemotherapy achieved better results than conventional treatment with minimal side effects, making immunotherapy one of the most promising treatments for tumors. Tweetable abstract Analysis of the #safety&efficacy of combined #PD-1inhibitors&chemotherapy in patients with #AdvancedPancreaticCancer Objective: To investigate the safety and efficacy of anti-PD-1 antibodies in combination with chemotherapy in the treatment of advanced pancreatic cancer. Methods: The clinical data of 18 patients with advanced pancreatic cancer who received anti-PD-1 antibody combined with chemotherapy were retrospectively analyzed. Safety, objective response rate, disease control rate, progression-free survival and overall survival were analyzed. Results: One patient achieved a complete response, nine patients had a partial response, five patients had stable disease and three patients had progressive disease. Progression-free survival and overall survival were shown to be significantly prolonged in both PD-L1-positive and high microsatellite instability (MSI-H) patients. Conclusion: Anti-PD-1 antibodies in combination with chemotherapy are safe and effective in the treatment of advanced pancreatic cancer.

引用

页码：1307 / 1313

页数：7

共 22 条

[11] Immune Checkpoint Inhibitors: Basics and Challenges [J].

Li, Bin ;

Chan, Ho Lam ;

Chen, Pingping .

CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) :3009-3025

[12] T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 [J].

Ott, Patrick A. ;

Bang, Yung-Jue ;

Piha-Paul, Sarina A. ;

Razak, Albiruni R. Abdul ;

Bennouna, Jaafar ;

Soria, Jean-Charles ;

Rugo, Hope S. ;

Cohen, Roger B. ;

O'Neil, Bert H. ;

Mehnert, Janice M. ;

Lopez, Juanita ;

Doi, Toshihiko ;

van Brummelen, Emilie M. J. ;

Cristescu, Razvan ;

Yang, Ping ;

Emancipator, Kenneth ;

Stein, Karen ;

Ayers, Mark ;

Joe, Andrew K. ;

Lunceford, Jared K. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) :318-+

[13] Pancreatic Cancer: A Review [J].

Park, Wungki ;

Chawla, Akhil ;

O'Reilly, Eileen M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (09) :851-862

[14] Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy [J].

Pitt, J. M. ;

Marabelle, A. ;

Eggermont, A. ;

Soria, J. -C. ;

Kroemer, G. ;

Zitvogel, L. .

ANNALS OF ONCOLOGY, 2016, 27 (08) :1482-1492

[15] A comprehensive catalogue of somatic mutations from a human cancer genome [J].

Pleasance, Erin D. ;

Cheetham, R. Keira ;

Stephens, Philip J. ;

McBride, David J. ;

Humphray, Sean J. ;

Greenman, Chris D. ;

Varela, Ignacio ;

Lin, Meng-Lay ;

Ordonez, Gonzalo R. ;

Bignell, Graham R. ;

Ye, Kai ;

Alipaz, Julie ;

Bauer, Markus J. ;

Beare, David ;

Butler, Adam ;

Carter, Richard J. ;

Chen, Lina ;

Cox, Anthony J. ;

Edkins, Sarah ;

Kokko-Gonzales, Paula I. ;

Gormley, Niall A. ;

Grocock, Russell J. ;

Haudenschild, Christian D. ;

Hims, Matthew M. ;

James, Terena ;

Jia, Mingming ;

Kingsbury, Zoya ;

Leroy, Catherine ;

Marshall, John ;

Menzies, Andrew ;

Mudie, Laura J. ;

Ning, Zemin ;

Royce, Tom ;

Schulz-Trieglaff, Ole B. ;

Spiridou, Anastassia ;

Stebbings, Lucy A. ;

Szajkowski, Lukasz ;

Teague, Jon ;

Williamson, David ;

Chin, Lynda ;

Ross, Mark T. ;

Campbell, Peter J. ;

Bentley, David R. ;

Futreal, P. Andrew ;

Stratton, Michael R. .

NATURE, 2010, 463 (7278) :191-U73

[16] A small-cell lung cancer genome with complex signatures of tobacco exposure [J].

Pleasance, Erin D. ;

Stephens, Philip J. ;

O'Meara, Sarah ;

McBride, David J. ;

Meynert, Alison ;

Jones, David ;

Lin, Meng-Lay ;

Beare, David ;

Lau, King Wai ;

Greenman, Chris ;

Varela, Ignacio ;

Nik-Zainal, Serena ;

Davies, Helen R. ;

Ordonez, Gonzalo R. ;

Mudie, Laura J. ;

Latimer, Calli ;

Edkins, Sarah ;

Stebbings, Lucy ;

Chen, Lina ;

Jia, Mingming ;

Leroy, Catherine ;

Marshall, John ;

Menzies, Andrew ;

Butler, Adam ;

Teague, Jon W. ;

Mangion, Jonathon ;

Sun, Yongming A. ;

McLaughlin, Stephen F. ;

Peckham, Heather E. ;

Tsung, Eric F. ;

Costa, Gina L. ;

Lee, Clarence C. ;

Minna, John D. ;

Gazdar, Adi ;

Birney, Ewan ;

Rhodes, Michael D. ;

McKernan, Kevin J. ;

Stratton, Michael R. ;

Futreal, P. Andrew ;

Campbell, Peter J. .

NATURE, 2010, 463 (7278) :184-U66

[17] Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database [J].

Seaton, Max ;

Hanna, Andrew ;

Boutros, Cherif ;

Hanna, Nader .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11

[18] Combination cancer immunotherapies tailored to the tumour microenvironment [J].

Smyth, Mark J. ;

Ngiow, Shin Foong ;

Ribas, Antoni ;

Teng, Michele W. L. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (03) :143-158

[19] T-cell-intrinsic and -extrinsic regulation of PD-1 function [J].

Sugiura, Daisuke ;

Shimizu, Kenji ;

Maruhashi, Takumi ;

Okazaki, Il-mi ;

Okazaki, Taku .

INTERNATIONAL IMMUNOLOGY, 2021, 33 (12) :693-698

[20] Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort [J].

Sun, Danyang ;

Ma, Junxun ;

Wang, Jinliang ;

Zhang, Fan ;

Wang, Lijie ;

Zhang, Sujie ;

Chen, Guangying ;

Li, Xiaoyan ;

Du, Wushuang ;

Cui, Pengfei ;

Hu, Yi .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 :1691-1700

← 1 2 3 →